Inappropriate use of antimicrobial medication contributes to the emergence of resistant organisms and causes patient harm.
Patients infected with resistant organisms are more likely to experience ineffective treatment, recurrent infection, delayed recovery or even death.
Help reduce inappropriate use of antibiotics
Safer Care Victoria supports antimicrobial stewardship (AMS) programs to help reduce inappropriate antimicrobial usage, improve patient outcomes and reduce adverse consequences of antimicrobial use, including antimicrobial resistance, toxicity and unnecessary costs.
Update your AMS program
National Safety and Quality Health Service Standards
The newly released NSQHS Preventing and Controlling Healthcare-Associated Infection Standard describes the requirements for your health service AMS program.
Organisations will be assessed against the new standards from January 2019.
Take part in the annual NAPS survey
The National Antimicrobial Prescribing Survey (NAPS) helps you:
- assess your antimicrobial prescribing practice
- determining prescribing trends and identifying targets for quality improvement
- meeting accreditation requirements for the Preventing and Controlling Healthcare Associated Infection Standard.
The survey was developed by the National Centre for Antimicrobial Stewardship (NCAS) and is endorsed by the Australian Commission on Safety and Quality in Health Care.
Stay up-to-date on best practice
As your hospital's AMS contact, there are many ways for you to keep across the latest developments in AMS.
Join the AMS network
Contact us to join the AMS network and get the latest updates and information for Victorian public and private hospital AMS contacts.
Or you can join the NCAS Journal Club, which meets every month at the Doherty Institute. Interested clinicians are invited to attend in person or by logging into the webinar.
Access online learning
Courses for doctors, pharmacists and nurses. Earn CPD points.
WHO’s newly developed course takes about eight hours to complete.
A six-week course from the University of Dundee, Scotland, and the British Society for Antimicrobial Chemotherapy (BSAC).
Page last updated: 20 Feb 2020